Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 19 of 1,261
  1. US 12391734

    PD-1 homing endonuclease variants, compositions, and methods of use

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  2. US 12391654

    CFTR regulators and methods of use thereof

    The Regents of the University of California · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  3. US 12391732

    Articles comprising a silk polypeptide for antigen delivery

    Ludwig-Maximilians-Universitat Munchen · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  4. US 12390419

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    AXSOME MALTA LTD. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  5. US 12390509

    Pharmaceutical composition comprising frataxin fusion protein and methods of use thereof

    Larimar Therapeutics, Inc. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  6. US 12390524

    Compositions and methods for inducing immune responses

    ARCTURUS THERAPEUTICS, INC. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  7. US 12390473

    Methods of treating tyrosine kinase inhibitor-induced diarrhea

    The Regents of the University of California · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  8. US 12390483

    Compounds and methods for treating neurological and cardiovascular conditions

    The Board of Regents of the University of Texas System · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  9. US 12391643

    Substituted amino-thiol and amino-disulfide compounds, and uses thereof

    The Regents of the University of California · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  10. US 12391920

    Models of tauopathy

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  11. US 12391765

    Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies

    Takeda Pharmaceutical Company Limited · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  12. US 12391923

    SIRPα-silenced natural killer (NK) cells

    The Regents of the University of California · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  13. US 12391753

    Antigen binding molecule formats

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  14. US 12391750

    Anti-C1S antibodies and methods of use thereof

    Bioverativ USA Inc. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  15. US 12391742

    Anti-KRAS-G12D T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  16. US 12391741

    T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof

    MiNK Therapeutics, Inc. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  17. US 12391739

    Method for producing gamma delta T cells

    Takeda Pharmaceutical Company Limited · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  18. US 12391658

    Sulfoxide and sulfone glucokinase activators and methods of use thereof

    VTV THERAPEUTICS LLC · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  19. US 12391663

    Isoindolinone compounds

    Monte Rosa Therapeutics AG · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  20. US 12391669

    Substituted pyrimidines as IRE1 kinase inhibitors

    The Regents of the University of California et al. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  21. US 12391720

    Salts and polymorphs of cethromycin for the treatment of disease

    AliquantumRx, Inc. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  22. US 12391686

    Compounds and uses thereof

    FOGHORN THERAPEUTICS INC. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  23. US 12390497

    Microbial strains for virus inhibition

    MICROBIAL DISCOVERY GROUP, LLC · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  24. US 12390427

    Plasminogen activator inhibitor-1 (PAI-1) inhibitor and method of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.